tiprankstipranks
pc:apnim

Apnimed Inc

Apnimed, Inc. is a private pharmaceutical company developing novel oral therapies for obstructive sleep apnea (OSA). Its lead product candidate, AD109, is an oral pill designed to treat OSA and is progressing through regulatory development with an upcoming NDA submission.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$150M
Total Amount Raised$150M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$150M
Latest Funding Amount$150M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 06, 2026
Investment
$150.00M

Investors

Investor Name
Funding Round

Related News and Analysis